The unexpected finding of pre-existing T-cell reactivity to the AstraZeneca and Janssen vaccines may explain why some people rarely developed thrombotic thrombocytopenia syndrome after vaccination.
The unexpected finding of pre-existing T-cell reactivity to the AstraZeneca and Janssen vaccines may explain why some people rarely developed thrombotic thrombocytopenia syndrome after vaccination.
Read More
Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45% compared to the traditional drug warfarin in the treatment of blood clots in the lungs and legs, according to a new long-term study.
Read More
This is the first time that the common respiratory virus has been reported to be associated with blood clots and severe thrombocytopenia, according to researchers.
Read More
Researchers found that the increased rate of post-discharge arterial thromboembolism (ATE) was more than 27%, and those with cardiovascular disease were at even higher risk.
Read More
Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.
Read More
Researchers who identified a novel mechanism for platelet activation in pathogenic blood clotting are now turning their attention to sepsis.
Read More
